Results 111 to 120 of about 165,999 (264)

Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients [PDF]

open access: yes, 2018
Phenylketonuria (PKU, MIM 261600) is an autosomal recessive disorder caused by mutations of the phenylalanine hydroxylase gene (PAH, GenBank U49897.1, RefSeq NM_000277). To date more than 560 variants of the PAH gene have been identified. In Europe there
Brunner-Krainz, Michaela   +12 more
core  

Manipulation of a cation-π sandwich reveals conformational flexibility in phenylalanine hydroxylase. [PDF]

open access: yesBiochimie, 2021
Arturo EC   +6 more
europepmc   +1 more source

Modulation of Human Phenylalanine Hydroxylase by 3-Hydroxyquinolin-2(1H)-One Derivatives. [PDF]

open access: yesBiomolecules, 2021
Lopes RR   +12 more
europepmc   +1 more source

The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response [PDF]

open access: yes, 2017
The discovery of a pharmacological treatment for phenylketonuria (PKU) raised new questions about function and dysfunction of phenylalanine hydroxylase (PAH), the enzyme deficient in this disease.
Blau, Nenad   +8 more
core  

CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria. [PDF]

open access: yesSci Rep, 2021
Singh K   +21 more
europepmc   +1 more source

Development of a mutation hotspot detection kit for the phenylalanine hydroxylase gene by ARMS-PCR combined with fluorescent probe technology. [PDF]

open access: yesBiosci Rep, 2021
Qiang R   +14 more
europepmc   +1 more source

The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase. [PDF]

open access: yesNat Commun, 2021
Aubi O   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy